Palisade Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,000
Closed -$225K 430
2021
Q4
$225K Buy
3,000
+200
+7% +$15K ﹤0.01% 414
2021
Q3
$325K Buy
+2,800
New +$325K 0.01% 381